Moingeon P - Search Results

1

Novel approaches and perspectives in allergen immunotherapy.

Hoffmann HJ, Valovirta E, Pfaar O, Moingeon P, Schmid JM, Skaarup SH, Cardell LO, Simonsen K, Larché M, Durham SR, Sørensen P. Hoffmann HJ, et al. Among authors: moingeon p. Allergy. 2017 Jul;72(7):1022-1034. doi: 10.1111/all.13135. Epub 2017 Mar 20. Allergy. 2017. PMID: 28122129 Free article. Review.

2

Immune mechanisms of allergen-specific sublingual immunotherapy.

Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Moingeon P, et al. Allergy. 2006 Feb;61(2):151-65. doi: 10.1111/j.1398-9995.2006.01002.x. Allergy. 2006. PMID: 16409190 Review.

3

Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.

Mascarell L, Van Overtvelt L, Moingeon P. Mascarell L, et al. Among authors: moingeon p. Immunol Allergy Clin North Am. 2006 May;26(2):283-306, vii-viii. doi: 10.1016/j.iac.2006.02.009. Immunol Allergy Clin North Am. 2006. PMID: 16701145 Review.

4

Sublingual immunotherapy: from biological extracts to recombinant allergens.

Moingeon P. Moingeon P. Allergy. 2006;61 Suppl 81:15-9. doi: 10.1111/j.1398-9995.2006.01157.x. Allergy. 2006. PMID: 16792601 Review.

5

Standardization of an ash (Fraxinus excelsior) pollen allergen extract.

Hrabina M, Purohit A, Oster JP, Papanikolaou I, Jain K, Pascal P, Sicard H, Gouyon B, Moingeon P, Pauli G, André C. Hrabina M, et al. Among authors: moingeon p. Int Arch Allergy Immunol. 2007;142(1):11-8. doi: 10.1159/000095994. Epub 2006 Sep 29. Int Arch Allergy Immunol. 2007. PMID: 17016054

6

Sublingual vaccines based on wild-type recombinant allergens.

Van Overtvelt L, Razafindratsita A, St-Lu N, Didierlaurent A, Batard T, Lombardi V, Martin E, Moingeon P. Van Overtvelt L, et al. Among authors: moingeon p. Eur Ann Allergy Clin Immunol. 2006 Sep;38(7):247-9. Eur Ann Allergy Clin Immunol. 2006. PMID: 17124785

7

Clinical trials with allergen products: in search of biological markers of efficacy.

Moingeon P. Moingeon P. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006;(95):182-7; discussion 187-8. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006. PMID: 17393738

8

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P. Razafindratsita A, et al. Among authors: moingeon p. J Allergy Clin Immunol. 2007 Aug;120(2):278-85. doi: 10.1016/j.jaci.2007.04.009. Epub 2007 May 25. J Allergy Clin Immunol. 2007. PMID: 17531296

9

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.

Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H, Mascarell L, Moingeon P. Van Overtvelt L, et al. Among authors: moingeon p. Int Arch Allergy Immunol. 2008;145(2):152-62. doi: 10.1159/000108140. Epub 2007 Sep 11. Int Arch Allergy Immunol. 2008. PMID: 17848808

10

Oral reactions to sublingual immunotherapy: a bioptic study.

Marcucci F, Sensi L, Incorvaia C, Di Cara G, Moingeon P, Frati F. Marcucci F, et al. Among authors: moingeon p. Allergy. 2007 Dec;62(12):1475-7. doi: 10.1111/j.1398-9995.2007.01519.x. Allergy. 2007. PMID: 17983387 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters